ARCHIVES

Harkin Withdraws Amendment Allow NIH To Bypass INDS

This article is from The Cancer Letter archive.

Vol. 18 No. 39 | October 9, 1992

Download PDF Visit The Full Archive

Related Articles

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

White Heads NIH Legislative Policy Office

March 5, 2010

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

In Brief: Ozols Promoted At Fox Chase; Greenberger Moves To Pittsburgh; ACR Names New Officers

October 8, 1993

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006